Also trades as: IPCALAB.BO (BSE) · $vol 1M
IPCALAB.NS NSE
Ipca Laboratories Limited
1W: -2.7%
1M: -2.2%
3M: +9.2%
YTD: +36.2%
1Y: +42.4%
3Y: +121.2%
5Y: +54.9%
₹1,964.00 ($20.40)
+20.80 (+1.07%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$123.7B
+5.2% ▲
5Y CAGR: +15.3%
Total Liabilities
$28.5B
-15.6% ▼
5Y CAGR: +16.0%
Shareholders Equity
$80.6B
+16.1% ▲
5Y CAGR: +11.4%
Cash & Investments
$12.0B
+8.2% ▲
5Y CAGR: +9.6%
Total Debt
$8.1B
-40.7% ▼
5Y CAGR: +25.0%
Net Debt
$2.4B
-76.0% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $2.8B | $12.6B | $2.1B | $1.7B | $5.6B |
| Short-Term Investments | $10.8B | $9.2B | $6.4B | $9.4B | $6.3B |
| Cash & ST Investments | $13.6B | $21.8B | $8.5B | $11.1B | $12.0B |
| Net Receivables | $9.2B | $10.0B | $16.9B | $19.2B | $20.6B |
| Inventory | $18.6B | $17.4B | $24.7B | $25.6B | $27.3B |
| Other Current Assets | $3.0B | $2.4B | $4.8B | $3.8B | $3.8B |
| Total Current Assets | $44.6B | $51.9B | $55.4B | $59.7B | $63.7B |
| Property, Plant & Equip. | $25.0B | $26.9B | $47.0B | $46.9B | $52.0B |
| Goodwill & Intangibles | $2.1B | $2.0B | $2.3B | $2.0B | $2.0B |
| Long-Term Investments | $3.5B | $3.0B | $4.1B | $2.8B | $3.2B |
| Other Non-Current Assets | $1.0B | $2.4B | $2.2B | $6.1B | $2.6B |
| Total Non-Current Assets | $31.7B | $34.4B | $55.6B | $57.9B | $60.0B |
| Total Assets | $76.2B | $86.3B | $111.0B | $117.6B | $123.7B |
| — Liabilities — | |||||
| Accounts Payable | $5.6B | $5.3B | $7.8B | $8.5B | $9.4B |
| Short-Term Debt | $4.0B | $8.1B | $8.1B | $7.6B | $5.9B |
| Deferred Revenue | $268M | $274M | $169M | $0 | $0 |
| Other Current Liabilities | $3.8B | $3.3B | $4.2B | $7.2B | $7.0B |
| Total Current Liabilities | $14.7B | $18.1B | $23.6B | $23.9B | $23.1B |
| Long-Term Debt | $4.0B | $6.5B | $5.8B | $5.4B | $1.1B |
| Other Non-Current Liab. | $453M | $470M | $877M | $970M | $983M |
| Total Non-Current Liabilities | $6.2B | $9.1B | $10.2B | $9.9B | $5.4B |
| Total Liabilities | $20.8B | $27.1B | $33.7B | $33.7B | $28.5B |
| — Equity — | |||||
| Common Stock | $254M | $254M | $254M | $254M | $254M |
| Retained Earnings | $40.4B | $44.0B | $49.0B | $55.3B | $0 |
| Accumulated OCI | $13.3B | $51M | $0 | $0 | $0 |
| Total Stockholders Equity | $54.9B | $58.4B | $63.3B | $69.5B | $80.6B |
| Total Liabilities & Equity | $76.2B | $86.3B | $111.0B | $117.6B | $123.7B |
| — Key Metrics — | |||||
| Total Debt | $8.1B | $14.8B | $14.4B | $13.6B | $8.1B |
| Net Debt | $5.3B | $2.2B | $12.3B | $10.2B | $2.4B |
| Total Investments | $14.4B | $12.2B | $10.5B | $12.1B | $9.5B |